Literature DB >> 18930099

Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques.

Akiko Takeda1, Hiroko Igarashi, Miki Kawada, Tetsuo Tsukamoto, Hiroyuki Yamamoto, Makoto Inoue, Akihiro Iida, Tsugumine Shu, Mamoru Hasegawa, Tetsuro Matano.   

Abstract

Viral vectors are promising vaccine tools for eliciting antigen-specific T-cell responses. We previously showed the potential of recombinant Sendai virus (SeV) vectors to induce virus-specific T-cell responses in macaque AIDS models. Here, we have evaluated the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted SeV vectors in macaques. Intranasal replication-competent and replication-defective SeV immunizations both elicited robust systemic antigen-specific T-cell responses, whereas the responses induced by the former were more durable than those by the latter. However, even the latter-induced T-cell responses remained detectable in a local, retropharyngeal lymph node two months after the immunization. These findings are useful for establishment of a vaccine protocol using SeV vectors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930099     DOI: 10.1016/j.vaccine.2008.09.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Authors:  Hiroki Takeuchi; Keiko Imamura; Bin Ji; Kayoko Tsukita; Takako Enami; Keizo Takao; Tsuyoshi Miyakawa; Masato Hasegawa; Naruhiko Sahara; Nobuhisa Iwata; Makoto Inoue; Hideo Hara; Takeshi Tabira; Maiko Ono; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi; Tetsuya Suhara; Makoto Higuchi; Haruhisa Inoue
Journal:  NPJ Vaccines       Date:  2020-03-25       Impact factor: 7.344

2.  Update on animal models for HIV research.

Authors:  Nancy L Haigwood
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

3.  Generation of integration-free and region-specific neural progenitors from primate fibroblasts.

Authors:  Jianfeng Lu; Huisheng Liu; Cindy Tzu-Ling Huang; Hong Chen; Zhongwei Du; Yan Liu; Mohammad Amin Sherafat; Su-Chun Zhang
Journal:  Cell Rep       Date:  2013-05-02       Impact factor: 9.423

4.  Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions.

Authors:  Chad C Macarthur; Andrew Fontes; Namritha Ravinder; David Kuninger; Jasmeet Kaur; Matthew Bailey; Antje Taliana; Mohan C Vemuri; Pauline T Lieu
Journal:  Stem Cells Int       Date:  2012-03-22       Impact factor: 5.443

5.  Human neural progenitors derived from integration-free iPSCs for SCI therapy.

Authors:  Ying Liu; Yiyan Zheng; Shenglan Li; Haipeng Xue; Karl Schmitt; Georgene W Hergenroeder; Jiaqian Wu; Yuanyuan Zhang; Dong H Kim; Qilin Cao
Journal:  Stem Cell Res       Date:  2017-01-05       Impact factor: 2.020

6.  Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy.

Authors:  Akram Al Abbar; Siew Ching Ngai; Nadine Nograles; Suleiman Yusuf Alhaji; Syahril Abdullah
Journal:  Biores Open Access       Date:  2020-04-28

7.  Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses.

Authors:  Hiroshi Ishii; Takushi Nomura; Hiroyuki Yamamoto; Masako Nishizawa; Trang Thi Thu Hau; Shigeyoshi Harada; Sayuri Seki; Midori Nakamura-Hoshi; Midori Okazaki; Sachie Daigen; Ai Kawana-Tachikawa; Noriyo Nagata; Naoko Iwata-Yoshikawa; Nozomi Shiwa; Tadaki Suzuki; Eun-Sil Park; Maeda Ken; Taishi Onodera; Yoshimasa Takahashi; Kohji Kusano; Ryutaro Shimazaki; Yuriko Suzaki; Yasushi Ami; Tetsuro Matano
Journal:  Cell Rep Med       Date:  2022-01-19

8.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome.

Authors:  Noemi Fusaki; Hiroshi Ban; Akiyo Nishiyama; Koichi Saeki; Mamoru Hasegawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493

9.  Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Authors:  Hiroki Takeuchi; Keiko Imamura; Bin Ji; Kayoko Tsukita; Takako Enami; Keizo Takao; Tsuyoshi Miyakawa; Masato Hasegawa; Naruhiko Sahara; Nobuhisa Iwata; Makoto Inoue; Hideo Hara; Takeshi Tabira; Maiko Ono; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi; Tetsuya Suhara; Makoto Higuchi; Haruhisa Inoue
Journal:  NPJ Vaccines       Date:  2020-03-24       Impact factor: 7.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.